• English
  • தமிழ்
  • বাংলা
  • മലയാളം
  • ગુજરાતી
  • हिंदी
  • मराठी
  • Business

The Financial Express

  • Whatsapp Whatsapp Link
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Google News Follow
Watchlist
  • Home
  • Business
  • Markets
  • Market Stats
  • T20 WC
  • IPO
  • Mutual Funds
  • Money
  • India News
  • Tech
  • US News
  • Shorts
  • ePaper
  • Defence Stocks
  • Gold Rate Today
  • AI Stocks
  • Mutual Funds
  • Semiconductor Stocks
  • Renewable Energy Stocks
  • EV Stocks
  • Ethanol Stocks
    • Home
    • T20 WORLD CUP 2026
    • Market
      • Stock Insights
      • Cryptocurrency
      • IPO News
      • Stock Market Quotes
      • Indices
      • Nifty 50
      • Sensex
      • Top Gainers
      • Top Losers
      • IPO Stats
    • Market Dashboard
    • Commodities
      • Gold Rate in India
      • Silver Rate in India
      • Petrol Rate in India
      • Diesel Rate in India
    • Opportunity Abroad
    • Money
      • Insurance
      • Income Tax
      • Mutual Funds News
      • MF Screener
    • Economy
    • Business
      • Brand Wagon
      • SME
      • Defence
      • Healthcare
    • Industry
      • Banking & Finance
    • India News
    • World News
    • Trending News
    • Jobs-Career
    • Infrastructure
      • Railways
      • Aviation
      • Roadways
    • Auto
    • Life
      • Lifestyle
      • Entertainment
      • Technology
      • Travel & Tourism
      • Science
    • Sports
    • Opinion
    • Multimedia
      • Photos
      • Web Stories
    • Events
    • ePaper
    • Today’s Paper
    • About us
    • PRIVACY POLICY
    • TERMS AND CONDITIONS
    • Contact Us

    1. Business News
    2. About
    3. dr reddys

    Dr Reddy’s

    • Click to share on Twitter (Opens in new window)
    • Click to share on Facebook (Opens in new window)
    • Click to share on WhatsApp (Opens in new window)
    Dr Reddy’s said the acquisition strengthens its gynaecology portfolio in India and marks its entry into the hormone replacement therapy segment.
    Dr Reddy’s enters hormone therapy market with $32.15 million Progynova deal

    The acquisition has been valued at $32.15 million (approximately Rs 295 crore), the company disclosed under Regulation 30 of Sebi’s…

    February 19, 2026 11:18 IST
    Q3 Earnings Peak: Complete Schedule for IndiGo, Adani, DLF, and 100+ Corporate Actions You Can't Miss (Source: AI-Generated)
    Q3 earnings peak: complete schedule for IndiGo, Adani, DLF and 100+ corporate actions you can’t miss

    Track 100 major Indian companies’ including Indigo, DLF, Adani Green, Eternal Q3 results, dividends, and stock splits this week—view the…

    January 18, 2026 08:00 IST
    Dr Reddy’s Laboratories reported a 6.36 per cent YoY profit growth in the second quarter
    Dr Reddy’s Q2 FY26 profit rises 6% YoY to Rs 1,426 crore; revenue up 9%

    Dr Reddy’s Q2 FY26 profit rises 6% YoY to ₹1,426 crore; revenue up 9% to Rs 8,805 crore, but margins…

    October 24, 2025 17:32 IST
    Why are pharma stocks falling?
    Three reasons why pharma stocks are falling today?

    Pharma stocks are under significant selling pressure. Here is a detailed analysis on the top worries for the sector.

    Updated: March 25, 2025 14:45 IST
    Dr Reddy's to distribute Sanofi’s paediatric and adult vaccine brands in India
    Dr Reddy’s to distribute Sanofi’s paediatric and adult vaccine brands in India

    The partnership with Sanofi gives Dr. Reddy’s a strong portfolio and major presence in the vaccine segment taking it to…

    March 27, 2024 17:59 IST
    The revenue of the Hyderabad-based company rose by 14% year-on-year to Rs 76,727 million, according to a BSE filing.
    Dr Reddy’s may join race to acquire Novartis’ India arm

    The exclusive sales and distribution agreement includes medicines such as the Voveran range, calcium range and Methergine.

    February 18, 2024 06:30 IST
    Dr Reddy’s Laboratories, Q2FY24 results, pharmaceutical, revenue, profit, EBITDA, capital expenditure, R&D investments, cash flow, Generics business, new products, Pharmaceutical Services and Active ingredients, price erosion
    Dr Reddy’s Q2 Results: Profit rises 30% to Rs 1482.20 crore, beats estimates

    Dr Reddy’s Laboratories posted revenue from operations at Rs 6902.60 crore, up 9 per cent as against Rs 6331.80 crore…

    October 27, 2023 17:16 IST
    dr reddys, dr reddys rating, dr reddys growth
    Rating: Reduce – Dr Reddy’s to focus on innovation

    Growth to be driven by over the counter drugs and specialty products

    June 27, 2023 02:30 IST
    Dr Reddy’s Laboratories, Q2FY24 results, pharmaceutical, revenue, profit, EBITDA, capital expenditure, R&D investments, cash flow, Generics business, new products, Pharmaceutical Services and Active ingredients, price erosion
    USFDA closes inspection at Dr Reddy’s API plant

    The inspection was conducted from June 12 to 16, 2023, and closed with zero observations.

    June 18, 2023 04:30 IST
    India, Dr Reddy
    India’s Dr Reddy’s Labs posts 11-fold jump in Q4 profit

    Dr Reddy’s consolidated revenue jumped 15.8% to 62.97 billion rupees, while total operating expenses fell 13.3%.

    May 10, 2023 19:20 IST
    Dr Reddys, Dr Reddys lab, Dr Reddys news, Dr Reddys founder, Dr Kallam Anji Reddy
    Dr Reddy’s to fulfil founder’s ‘unfinished agenda’ on new drug discovery

    Ten years since his passing, the company, led by his family, organised the first Dr Anji Reddy Memorial Lecture on…

    Updated: March 15, 2023 18:54 IST
    Dr reddy's. market
    Rating: buy; Dr Reddy’s and Mayne deal is a valuable investment

    Despite competitive generics mkt, purchase is a good investment.

    March 6, 2023 04:10 IST
    Dr Reddy’s Q2 net profit beats estimates, up 12%

    The company’s revenue went up 9% to Rs 6,306 crore as against Rs 5,763 crore while it reported an Ebitda…

    October 29, 2022 03:30 IST
    Dr Reddy's
    Generic Revlimid pays off: Dr Reddy’s PAT up 12 pc at Rs 1,113 cr in Q2

    The company launched generic Revlimid (Lenalidomide) capsules in the US market during the quarter.

    October 28, 2022 18:53 IST
    Dr. Reddys, Dr Reddys laboratories, Bortezomib, health news, pharma news,
    Dr. Reddy’s Laboratories launches Bortezomib for Injection in US

    Meanwhile, Dr. Reddy’s Bortezomib for Injection is supplied in a 3.5 mg per 10 mL single-dose vial presentation for subcutaneous…

    Updated: July 27, 2022 21:15 IST
    Dr Reddys, Dr Reddy labs, health news, pharma news,
    Dr Reddy’s sets its goal to triple its reach to 1.5 billion patients by 2030

    The company also said it will have three innovative products improving the standard of treatment every year. On carbon emissions,…

    July 7, 2022 20:24 IST
    Dr Reddys, Dr Reddy labs, health news, pharma news,
    Dr Reddy’s settles patent litigation with Indivior, Aquestive Therapeutics

    On June 28, 2022, a US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to…

    June 30, 2022 12:01 IST
    Dr Reddy's, Sorafenib tablets, health news, pharma news,
    Dr Reddy’s share price soars 9.5% in 5 days, brokerages expect another 15% jump; check target price

    Dr Reddy’s share price has jumped 9.5% in the last five days. The stock has rallied after the company last…

    May 23, 2022 10:44 IST
    • 1
    • 2
    • Next

    Related News

    Dubai Live news mArch 8
    Dubai, UAE, Iran War LIVE Updates: Indian Embassy in UAE issues social media advisory; drone attacks wreak havoc in Beirut, Kuwait
    Powering Profits: Is this PSU the ultimate dividend play for your portfolio? (AI generated image from Gemini)
    6% yield & zero debt: Is this PSU the ultimate ‘Dividend Hunter’ pick for FY27?
    Beyond the fabs: Uncovering the hidden value in India’s semiconductor ecosystem. (AI generated image from Gemini)
    Not Tata Elxsi, Not Dixon: 2 under-the-radar stocks front-running India’s Rs 76,000-crore chip surge
    Trump russian oil India
    ‘Oil pressure’: Trump breaks silence on Russian crude sales ‘permission’ to India after Bessent interview
    Are these small-cap players the next strategic pillars of Atmanirbhar Bharat? (AI generated image from Gemini)
    2 Defence stocks to watch as India pivots to proprietary nuclear and maritime tech
    shorts
    West Asia crisis: MEA says over 52,000 Indians back home from Gulf nations
    West Asia crisis: MEA says over 52,000 Indians back home from Gulf nations
    India News35 min ago

    In just one week, over 52,000 Indian nationals have returned from the Gulf region, with 32,107 on Indian airlines. The government is closely monitoring the situation and providing aid to those affected by travel disruptions. Indian missions have established helplines and are urging citizens to register for assistance.

    View all shorts

    Trending Topics

    defence stocks
    Gold rate today
    Silver rate today
    AI stocks
    mutual funds
    semiconductor stocks

    Top Categories
    • Market
    • India News
    • Stock Insights
    • Money
    • Opportunities Abroad
    • World News
    • Latest News
    • Technology
    • ITR Guide
    • Money Insights
    Stock Screeners
    • Stock Screener
    • Break Out Stocks
    • Defence Stocks
    • Consistently Growing Stocks
    • Low Price Blue Chip Stocks
    Top NSE/BSE Companies Share Price
    • Tata Motors share price
    • Tata Steel share price
    • State Bank Of India share price
    • HDFC Bank share price
    • Infosys share price
    • ITC share price
    • Wipro share price
    • NTPC share price
    • ongc share price
    • Adani Enterprises share price
    • Adani Ports and Special Economic Zone share price
    • Bharat Petroleum Corporation share price
    • Coal India share price
    • Bajaj Finance share price
    • ICICI Bank share price
    • Titan Company share price
    • Larsen & Toubro share price
    • Power Grid Corporation Of India share price
    • Asian Paints share price
    Gold Price in Top Metro Cities
    • Gold Rate Today
    • Gold Rate in Dubai
    • Gold Rate in Chennai
    • Gold Rate in Kerala
    • Gold Rate in Hyderabad
    • Gold Rate in Bangalore
    • Gold Rate in Mumbai
    • Gold Rate in Noida
    • Gold Price in Delhi
    • Gold Price in Ahmedabad
    • Gold Price in Kolkata
    Latest News
    • Samsung reportedly increases prices of several smartphones in India: Check the updated rates here
    • West Asia crisis: MEA says over 52,000 Indians back home from Gulf nations; embassies ask citizens to register, more flights planned
    • Shah Rukh Khan, Anurag Kashyap praise Subedaar, call Anil Kapoor’s performance ‘restrained yet powerful’
    • Green Card timeline gets clearer as Department of Labor posts March 5 processing update
    • India vs New Zealand T20 World Cup Final: The Factory, The Garden, and a World Cup Curse That Must Die
    Follow Us
    • Facebook Facebook Link
    • Twitter Twitter Link
    • Linkedin Linkedin Link
    Download Apps
    • Play_stor Play_stor Link
    • Apple_stor Apple_stor Link
    Express Group
    • INDIAN EXPRESS GROUP
    • The Indian Express
    • Loksatta
    • Jansatta
    • Inuth
    • Ramnath Goenka Awards
    • IE Tamil
    • IE Malayalam
    • IE Bangla
    • IE Gujarati
    • IE Education
    • This website follows the DNPA’s code of conduct
    Quick Links
    • T&C
    • Privacy Policy
    • CONTACT US
    • About Us
    Copyright © 2026 The Indian Express [P] Ltd. All Rights Reserved
    Market Pulse